{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:11:42Z","timestamp":1792188702131,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T00:00:00Z","timestamp":1310428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T00:00:00Z","timestamp":1310428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/mp.2011.82","type":"journal-article","created":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T04:17:21Z","timestamp":1310444241000},"page":"642-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":539,"title":["Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers"],"prefix":"10.1038","volume":"17","author":[{"given":"J","family":"Hirvonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R S","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-T","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V W","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,12]]},"reference":[{"key":"BFmp201182_CR1","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","volume":"5","author":"L Degenhardt","year":"2008","unstructured":"Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5: e141.","journal-title":"PLoS Med"},{"key":"BFmp201182_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","volume":"374","author":"W Hall","year":"2009","unstructured":"Hall W, Degenhardt L . Adverse health effects of non-medical cannabis use. Lancet 2009; 374: 1383\u20131391.","journal-title":"Lancet"},{"key":"BFmp201182_CR3","doi-asserted-by":"publisher","first-page":"143S","DOI":"10.1002\/j.1552-4604.1981.tb02589.x","volume":"21","author":"RT Jones","year":"1981","unstructured":"Jones RT, Benowitz NL, Herning RI . Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 1981; 21: 143S\u2013152S.","journal-title":"J Clin Pharmacol"},{"key":"BFmp201182_CR4","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","volume":"33","author":"DC D'Souza","year":"2008","unstructured":"D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T et al. Blunted psychotomimetic and amnestic effects of \u0394-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 2008; 33: 2505\u20132516.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201182_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0269881108092393","volume":"23","author":"JG Ramaekers","year":"2009","unstructured":"Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR . Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 2009; 23: 266\u2013277.","journal-title":"J Psychopharmacol"},{"key":"BFmp201182_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s002130050849","volume":"141","author":"M Haney","year":"1999","unstructured":"Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW . Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 1999; 141: 395\u2013404.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp201182_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/09540260902782752","volume":"21","author":"ZD Cooper","year":"2009","unstructured":"Cooper ZD, Haney M . Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry 2009; 21: 104\u2013112.","journal-title":"Int Rev Psychiatry"},{"key":"BFmp201182_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","volume":"58","author":"MA Huestis","year":"2001","unstructured":"Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET et al. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 2001; 58: 322\u2013328.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201182_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00213-007-0861-5","volume":"194","author":"MA Huestis","year":"2007","unstructured":"Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G et al. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl) 2007; 194: 505\u2013515.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp201182_CR10","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp201182_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL . Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299\u2013318.","journal-title":"Neuroscience"},{"key":"BFmp201182_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161\u2013202.","journal-title":"Pharmacol Rev"},{"key":"BFmp201182_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA . Endocannabinoid signaling in the brain. Science 2002; 296: 678\u2013682.","journal-title":"Science"},{"key":"BFmp201182_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pbb.2005.01.028","volume":"81","author":"S Gonzalez","year":"2005","unstructured":"Gonzalez S, Cebeira M, Fernandez-Ruiz J . Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav 2005; 81: 300\u2013318.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp201182_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","volume":"15","author":"LJ Sim-Selley","year":"2003","unstructured":"Sim-Selley LJ . Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 2003; 15: 91\u2013119.","journal-title":"Crit Rev Neurobiol"},{"key":"BFmp201182_CR16","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","volume":"73","author":"CS Breivogel","year":"1999","unstructured":"Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Vogt LJ, Sim-Selley LJ . Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 1999; 73: 2447\u20132459.","journal-title":"J Neurochem"},{"key":"BFmp201182_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0006-8993(93)90220-H","volume":"616","author":"A Oviedo","year":"1993","unstructured":"Oviedo A, Glowa J, Herkenham M . Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 1993; 616: 293\u2013302.","journal-title":"Brain Res"},{"key":"BFmp201182_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/jpet.102.035618","volume":"303","author":"LJ Sim-Selley","year":"2002","unstructured":"Sim-Selley LJ, Martin BR . Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta 9-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 2002; 303: 36\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp201182_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0014-2999(02)02854-6","volume":"459","author":"C Breivogel","year":"2003","unstructured":"Breivogel C, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR . The effects of \u03949-tetrahydrocannabinol physical dependence on brain cannabinoid receptors. Eur J Pharmacol 2003; 459: 139\u2013150.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201182_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1124\/mol.105.019612","volume":"70","author":"LJ Sim-Selley","year":"2006","unstructured":"Sim-Selley LJ, Schechter NS, Rorrer WK, Dalton GD, Hernandez J, Martin BR et al. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol Pharmacol 2006; 70: 986\u2013996.","journal-title":"Mol Pharmacol"},{"key":"BFmp201182_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.107.130328","volume":"324","author":"DL McKinney","year":"2008","unstructured":"McKinney DL, Cassidy MP, Collier LM, Martin BR, Wiley JL, Selley DE et al. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to 9-tetrahydrocannabinol. J Pharmacol Exp Ther 2008; 324: 664\u2013673.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp201182_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2967\/jnumed.109.067074","volume":"51","author":"GE Terry","year":"2010","unstructured":"Terry GE, Hirvonen J, Liow JS, Zoghbi SS, Gladding R, Tauscher JT et al. Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands. J Nucl Med 2010; 51: 112\u2013120.","journal-title":"J Nucl Med"},{"key":"BFmp201182_CR23","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1021\/jm800416m","volume":"51","author":"SR Donohue","year":"2008","unstructured":"Donohue SR, Krushinski JH, Pike VW, Chernet E, Phebus L, Chesterfield AK et al. Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging. J Med Chem 2008; 51: 5833\u20135842.","journal-title":"J Med Chem"},{"key":"BFmp201182_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1046\/j.1360-0443.2001.967102312.x","volume":"96","author":"SJ Heishman","year":"2001","unstructured":"Heishman SJ, Singleton EG, Liguori A . Marijuana craving questionnaire: development and initial validation of a self-report instrument. Addiction 2001; 96: 1023\u20131034.","journal-title":"Addiction"},{"key":"BFmp201182_CR25","first-page":"520","volume":"47","author":"SS Zoghbi","year":"2006","unstructured":"Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS et al. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. J Nucl Med 2006; 47: 520\u2013527.","journal-title":"J Nucl Med"},{"key":"BFmp201182_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jps.2600830718","volume":"83","author":"MS Gandelman","year":"1994","unstructured":"Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB . Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. J Pharm Sci 1994; 83: 1014\u20131019.","journal-title":"J Pharm Sci"},{"key":"BFmp201182_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273\u2013289.","journal-title":"Neuroimage"},{"key":"BFmp201182_CR28","first-page":"277","volume":"39","author":"C Burger","year":"1998","unstructured":"Burger C, Mikolajczyk K, Grodzki M, Rudnicki P, Szabatin M, Buck A . Java tools for quantitative post-processing of brain PET data. J Nucl Med 1998; 39: 277\u2013278.","journal-title":"J Nucl Med"},{"key":"BFmp201182_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"KJ Friston","year":"1995","unstructured":"Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith C, Frackowiak RSJ . Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189\u2013210.","journal-title":"Hum Brain Mapp"},{"key":"BFmp201182_CR30","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 27: 1533\u20131539.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFmp201182_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/jat\/33.8.469","volume":"33","author":"EL Karschner","year":"2009","unstructured":"Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL et al. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. J Anal Toxicol 2009; 33: 469\u2013477.","journal-title":"J Anal Toxicol"},{"key":"BFmp201182_CR32","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/j.1360-0443.2009.02705.x","volume":"104","author":"EL Karschner","year":"2009","unstructured":"Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R et al. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 2009; 104: 2041\u20132048.","journal-title":"Addiction"},{"key":"BFmp201182_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","volume":"105","author":"RH Lowe","year":"2009","unstructured":"Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA . Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend 2009; 105: 24\u201332.","journal-title":"Drug Alcohol Depend"},{"key":"BFmp201182_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/syn.890100302","volume":"10","author":"RB Innis","year":"1992","unstructured":"Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP et al. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse 1992; 10: 177\u2013184.","journal-title":"Synapse"},{"key":"BFmp201182_CR35","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.neuroimage.2008.03.004","volume":"41","author":"G Terry","year":"2008","unstructured":"Terry G, Liow J, Chernet E, Zoghbi S, Phebus L, Felder C et al. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. Neuroimage 2008; 41: 690\u2013698.","journal-title":"Neuroimage"},{"key":"BFmp201182_CR36","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/0024-3205(96)00085-9","volume":"58","author":"M Rinaldi-Carmona","year":"1996","unstructured":"Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A et al. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci 1996; 58: 1239\u20131247.","journal-title":"Life Sci"},{"key":"BFmp201182_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuroscience.2006.11.012","volume":"145","author":"J Villares","year":"2007","unstructured":"Villares J . Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience 2007; 145: 323\u2013334.","journal-title":"Neuroscience"},{"key":"BFmp201182_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","volume":"25","author":"BR Martin","year":"2004","unstructured":"Martin BR, Sim-Selley LJ, Selley DE . Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 2004; 25: 325\u2013330.","journal-title":"Trends Pharmacol Sci"},{"key":"BFmp201182_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0074-7742(06)78010-2","volume":"78","author":"DC D'Souza","year":"2007","unstructured":"D'Souza DC . Cannabinoids and psychosis. Int Rev Neurobiol 2007; 78: 289\u2013326.","journal-title":"Int Rev Neurobiol"},{"key":"BFmp201182_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1369-1600.2007.00095.x","volume":"13","author":"ZD Cooper","year":"2008","unstructured":"Cooper ZD, Haney M . Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol 2008; 13: 188\u2013195.","journal-title":"Addict Biol"},{"key":"BFmp201182_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/dmrr.764","volume":"23","author":"D Cota","year":"2007","unstructured":"Cota D . CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes Metab Res Rev 2007; 23: 507\u2013517.","journal-title":"Diabetes Metab Res Rev"},{"key":"BFmp201182_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nn.2494","volume":"13","author":"L Bellocchio","year":"2010","unstructured":"Bellocchio L, Lafen\u00eatre P, Cannich A, Cota D, Puente N, Grandes P et al. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 2010; 13: 281\u2013283.","journal-title":"Nat Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp201182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp201182","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp201182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:33:52Z","timestamp":1648769632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFmp201182"],"URL":"https:\/\/doi.org\/10.1038\/mp.2011.82","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12160957.13320055","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,12]]},"assertion":[{"value":"24 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}